Padeliporfin di-potassium | Interleukin Related interleukin-related.com

Product Name :
Padeliporfin di-potassium

Search keywords :
Taurine

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Vascular disrupting agents (VDA)

First Approval Country :
EU

First Approval Date Filter:
2017

Origin Company_Name :
Steba Biotech Sa

Active Company_Name :
Impact Biotech Ltd

Active Indication_Name:
Prostatic Neoplasms

In Active Indication_Name:
Cholangiocarcinoma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tositumomab medchemexpress
Utomilumab MedChemExpress
GRP78 BiP Antibody: GRP78 BiP Antibody is a non-conjugated and Mouse origined monoclonal antibody about 72kDa, targeting to GRP78 BiP. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts